MDClone

MDClone is an Israeli health-data technology company focused on enabling healthcare organizations to analyze and share clinical data without exposing patient-level records. The company's core approach uses synthetic data generation — producing statistically representative datasets derived from real patient records — to allow researchers, clinicians, and administrators to work with realistic health data while preserving privacy.

MDClone's platform is designed for health systems, academic medical centers, and life-science organizations that need to query large clinical datasets for research, real-world evidence generation, and operational analytics. By generating synthetic patient cohorts that mirror the statistical properties of real populations, the platform allows queries and analyses that would otherwise require complex de-identification workflows or be blocked by privacy regulations. The primary buyers are hospital informatics teams, clinical research offices, and pharmaceutical or biotech companies seeking real-world evidence.

MDClone operates out of Israel, where its core R&D is based. The company has pursued partnerships with major U.S. health systems, including a notable collaboration with Duke Health, which has been publicly referenced in connection with the platform's deployment for clinical research. Detailed public information on headcount, office locations within Israel, or specific funding rounds is limited.